PR Newswire04.19.17
USGI Medical Inc. (USGI), a company dedicated to advancing incisionless, endoluminal procedures for weight loss, reflux, and advanced therapeutic endoscopy, announced the appointment of Carlos Babini as the president and chief executive officer. Babini, a world-class commercialization expert, brings more than 25 years of successful leadership experience to USGI, with distinguished performance in both public and private sectors of medical device companies.
Babini previously served as vice president of AirSeal System Commercialization for CONMED Corporation (CONMED), and chief commercialization officer at SurgiQuest Inc. (SurgiQuest), a medical company offering surgical devices and equipment for laparoscopic and robotic surgical procedures, prior to being acquired by CONMED. Mr. Babini also served as president, international for Curon Inc. and chief sales and marketing officer of the medical segment of Vision Sciences Inc., and held various senior management positions at United States Surgical Corporation prior to its acquisition by Tyco, and subsequently by Medtronic.
"I am delighted to join USGI Medical at this critical time as the company continues to establish the Pose procedure as a credible option for clinicians who have patients seeking clinical assistance to achieve weight loss," said Babini. "This procedure has the potential to help millions of obese patients globally who have not been able to keep weight off through diet and exercise alone, and who may not be candidates for, nor able to undertake the possible risks associated with invasive bariatric surgery."
"I have had the pleasure of working with Mr. Babini during this initial period and in a very short time, already experienced positive momentum and engagement with the entire USGI team," said Scott Moonly, Executive Chairman of USGI, previous CEO. Also, Guy Nohra, member of the USGI Board of Directors, Managing Director, Alta Partners, stated, "We are most pleased to have Mr. Babini on board and the level of skill set and leadership know-how that he brings on board. It is clear that he is committed to excellence!"
Babini previously served as vice president of AirSeal System Commercialization for CONMED Corporation (CONMED), and chief commercialization officer at SurgiQuest Inc. (SurgiQuest), a medical company offering surgical devices and equipment for laparoscopic and robotic surgical procedures, prior to being acquired by CONMED. Mr. Babini also served as president, international for Curon Inc. and chief sales and marketing officer of the medical segment of Vision Sciences Inc., and held various senior management positions at United States Surgical Corporation prior to its acquisition by Tyco, and subsequently by Medtronic.
"I am delighted to join USGI Medical at this critical time as the company continues to establish the Pose procedure as a credible option for clinicians who have patients seeking clinical assistance to achieve weight loss," said Babini. "This procedure has the potential to help millions of obese patients globally who have not been able to keep weight off through diet and exercise alone, and who may not be candidates for, nor able to undertake the possible risks associated with invasive bariatric surgery."
"I have had the pleasure of working with Mr. Babini during this initial period and in a very short time, already experienced positive momentum and engagement with the entire USGI team," said Scott Moonly, Executive Chairman of USGI, previous CEO. Also, Guy Nohra, member of the USGI Board of Directors, Managing Director, Alta Partners, stated, "We are most pleased to have Mr. Babini on board and the level of skill set and leadership know-how that he brings on board. It is clear that he is committed to excellence!"